# Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine for Intermediate Cervical Plexus Block

> **NCT05793060** · PHASE4 · RECRUITING · sponsor: **Damanhour Teaching Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride
- **DRUG:** Dexamethasone Phosphate

## Key facts

- **NCT ID:** NCT05793060
- **Lead sponsor:** Damanhour Teaching Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05793060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05793060, "Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine for Intermediate Cervical Plexus Block". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05793060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*